Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022	$ 4,084,649	$ 334	$ 119,731,458	$ (115,647,143)
Beginning Balance, Shares at Dec. 31, 2022		3,343,070
Stock-based compensation expense	284,572		284,572
Net loss	(2,243,070)			(2,243,070)
Ending Balance at Mar. 31, 2023	2,126,151	$ 334	120,016,030	(117,890,213)
Ending Balance, Shares at Mar. 31, 2023		3,343,070
Beginning Balance at Dec. 31, 2023	$ (2,579,537)	$ 334	120,859,567	(123,439,438)
Beginning Balance, Shares at Dec. 31, 2023	3,343,070	3,343,070
Stock-based compensation expense	$ 254,029		254,029
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs	6,172,623	$ 513	6,172,110
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs, shares		5,134,731
Amendment and issuance of common stock and Pre-Funded Warrants from exercise of Series B Warrants, net of issuance costs	1,229,874	$ 12	1,229,862
Amendment and issuance of common stock and Pre-Funded Warrants from exercise of Series B Warrants, net of issuance costs, shares		119,604
Net loss	(1,579,820)			(1,579,820)
Ending Balance at Mar. 31, 2024	$ 3,497,169	$ 859	$ 128,515,568	$ (125,019,258)
Ending Balance, Shares at Mar. 31, 2024	8,597,405	8,597,405